Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester

olmesartan has been researched along with n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester in 2 studies

Compound Research Comparison

Studies
(olmesartan)		Trials
(olmesartan)		Recent Studies (post-2010)
(olmesartan)		Studies
(n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester)		Trials
(n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester)		Recent Studies (post-2010) (n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester)
8411855543311239

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester (IC50)
Presenilin-1Homo sapiens (human)0.2071
Presenilin-2Homo sapiens (human)0.2071
Gamma-secretase subunit APH-1BHomo sapiens (human)0.2071
NicastrinHomo sapiens (human)0.2071
Gamma-secretase subunit APH-1AHomo sapiens (human)0.2071
Gamma-secretase subunit PEN-2Homo sapiens (human)0.2071

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Ge, J; Guo, J; Jiang, G; Li, L; Wang, S; Wu, J; You, J; Zou, Y1

Other Studies

2 other study(ies) available for olmesartan and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
    Journal of cardiovascular pharmacology, 2013, Volume: 61, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium-Binding Proteins; Dipeptides; Disease Models, Animal; Fibrosis; Hypertrophy, Left Ventricular; Imidazoles; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Microcirculation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptor, Notch1; Tetrazoles; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Remodeling

2013